CIK: 0001599719 · Show all filings
Period: Q1 2017 (← Previous) (Next →)
Filing Date: May 30, 2017
Total Value ($000): $1,384,743 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| VNQ | VANGUARD INDEX FDS | 9,459,224 | $781,237 | 56.4% | $75.13 | — | REIT ETF | 922908553 |
| SPY | SPDR S&P 500 ETF TR | 1,945,160 | $458,551 | 33.1% | $224.64 | — | TR UNIT | 78462F103 |
| ORA | ORMAT TECHNOLOGIES INC | 728,326 | $41,573 | 3.0% | $24.60 | +112.2% | COM | 686688102 |
| OPK | OPKO HEALTH INC | 5,061,154 | $40,489 | 2.9% | $10.44 | -19.4% | COM | 68375N103 |
| EEM | ISHARES TR | 549,080 | $21,628 | 1.6% | $38.78 | — | MSCI EMG MKT ETF | 464287234 |
| EWJ | ISHARES | 380,456 | $19,594 | 1.4% | $36.08 | — | MSCI JAPAN ETF | 46434G822 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 195,289 | $6,267 | 0.5% | $57.15 | — | ADR | 881624209 |
| IHE | ISHARES TR U.S. PHARMA ETF | 38,300 | $5,781 | 0.4% | $150.94 | — | PHARMA ETF | 464288836 |
| VWO | VANGUARD INTL EQUITY INDEX F | 112,774 | $4,479 | 0.3% | $38.17 | — | FTSE EMR MKT ETF | 922042858 |
| VPL | VANGUARD INTL EQUITY INDEX F | 41,503 | $2,626 | 0.2% | $60.62 | — | FTSE PACIFIC ETF | 922042866 |
| EPP | ISHARES | 15,604 | $697 | 0.1% | $41.88 | — | MSCI PAC JP ETF | 464286665 |
| IWM | ISHARES RUSSEL 2000 ETF | 5,035 | $692 | 0.0% | $134.85 | — | WTH | 464287655 |
| XLU | SELECT SECTOR SPDR TR | 13,466 | $691 | 0.0% | $52.45 | — | SBI INT-UTILS | 81369Y886 |
| — | POWERSHARES QQQ TRUST | 3,313 | $438 | 0.0% | $91.95 | — | UNIT SER 1 | 73935A104 |